SPP1 and postmenopausal osteoporosis: Bone-derived hormone studies have further expanded the scope of biomarkers: As an anti-aging factor alleviating cognitive decline [310], OPN is significantly elevated in both postmenopausal osteoporosis and AD pathological processes [311].